Prognostic factors in primary central nervous system lymphomas.
Efforts to identify survival predictors in primary central nervous system lymphoma (PCNSL) have produced isolated, unconfirmed observations in small retrospective and prospective series. Age and performance status are two unanimously accepted prognostic factors. These and other independent predictors of survival were used by the International Extranodal Lymphoma Study Group (IELSG) to establish a prognostic scoring system able to distinguish risk groups in PCNSL. The IELSG score will improve further with better knowledge of these malignancies, especially with the inclusion of molecular and pharmacogenetic variables able to identify lymphomas with different chemosensitivities or degrees of aggressiveness. In the years ahead, a well-established prognostic score will allow the separation of patients into risk groups, which could result in the application of risk-tailored therapeutic strategies.
Ferreri
Andrés J M
AJ
Medical Oncology Unit, Department of Oncology, San Raffaele H Scientific Institute, Via Olgettina 60, 20132 Milan, Italy. andrew.ferreri@hsr.it
Reni
Michele
M
D017677:Age Distribution; D014408:Biomarkers, Tumor / Q000378:metabolism; D016543:Central Nervous System Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate
D014408:Biomarkers, Tumor